Dr. Campbell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15700 37th Ave N
#300
Minneapolis, MN 55446Phone+1 612-871-1145
Education & Training
University of MinnesotaFellowship, Gastroenterology, 2018 - 2021- University of MinnesotaChief Residency, Internal Medicine, 2017 - 2018
- University of MinnesotaResidency, Internal Medicine, 2014 - 2017
Medical College of WisconsinClass of 2014
Certifications & Licensure
MN State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 16 citationsVedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease.Byron P. Vaughn, Andres Yarur, Elliot Graziano, James P. Campbell, Abhik Bhattacharya
Journal of Clinical Medicine. 2020-09-28 - 31 citationsComparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.Dana J. Lukin, David Faleck, Ronghui Xu, Yiran Zhang, A Weiss
Clinical Gastroenterology and Hepatology. 2020-10-08 - 17 citationsSarcopenia Is More Prevalent Among Inflammatory Bowel Disease Patients Undergoing Surgery and Predicts Progression to Surgery Among Medically Treated Patients.James P Campbell, Levi Teigen, Scott Manski, Brian Blumhof, Flavius F Guglielmo
Inflammatory Bowel Diseases. 2022-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
